{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T11:23:24Z","timestamp":1773833004755,"version":"3.50.1"},"reference-count":15,"publisher":"S.C. JURNALUL PENTRU MEDICINA SI VIATA S.R.L","issue":"3","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JMedLife"],"abstract":"<jats:p>The COVID-19 pandemic has highlighted the potential impact of this disease on cardiovascular morbidity and mortality. Patients with established cardiovascular (CV) disease are at increased risk of severe infection and hospital-acquired adverse outcomes. This study aimed to investigate the prevalence and characteristics of comorbidities in COVID-19 patients. We analyzed data from 220 patients who previously contracted COVID-19. Statistical analysis was performed using SPSS software. The average age of the patients was 54.6 \u00b1 11.4 years, and arterial hypertension (AH) was the most common comorbidity, affecting 55% of patients. Obesity was observed in one-third of patients, while coronary heart disease (CHD) and coronary heart failure (CHF) were reported in 17.7% and 11.8% of patients, respectively. Chronic kidney disease (CKD), atrial fibrillation (AF), and obstructive pulmonary disease (COPD) were less common. Cardiovascular diseases, particularly AH, were the most frequent comorbidities in COVID-19 patients. Understanding the prevalence and characteristics of comorbidities in COVID-19 patients is crucial for developing appropriate management strategies and improving clinical outcomes. Our findings highlight the importance of identifying and managing comorbidities in COVID-19 patients to reduce the risk of severe COVID-19 and improve clinical outcomes.<\/jats:p>","DOI":"10.25122\/jml-2022-0168","type":"journal-article","created":{"date-parts":[[2023,5,8]],"date-time":"2023-05-08T02:32:41Z","timestamp":1683513161000},"page":"447-450","source":"Crossref","is-referenced-by-count":6,"title":["Occurrence of comorbid diseases in patients after COVID-19"],"prefix":"10.25122","volume":"16","author":[{"given":"Umida","family":"Kamilova","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Department of Therapy, Tashkent Medical Academy, Tashkent, Uzbekistan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"* Corresponding Author: Umida Kamilova, Department of Therapy, Tashkent Medical Academy, Tashkent, Uzbekistan. E-mail: umida_kamilova@mail.ru","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akbal","family":"Ermekbaeva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Department of Therapy, Tashkent Medical Academy, Tashkent, Uzbekistan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nuriddin","family":"Nuritdinov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Department of Cardiology, Republican Specialized Scientific and Practical Medical Center of Therapy and Medical Rehabilitation, Tashkent, Uzbekistan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abror","family":"Khamraev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Department of Therapy, Tashkent Medical Academy, Tashkent, Uzbekistan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gulnoza","family":"Zakirova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10755","published-online":{"date-parts":[[2023,3]]},"reference":[{"key":"ref1","unstructured":"1. COVID-19 rapid guideline: managing the long-term effects of COVID-19 (NG188): Evidence review 5: interventions. London: National Institute for Health and Care Excellence (UK). NICE Guideline 2020;(188). Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK567264"},{"key":"ref2","unstructured":"2. Brieghel C, Ellekvist P, Lund ML, S\u00f8borg C, et al. Prognostic factors of 90-day mortality in patients hospitalised with COVID-19. Dan Med J. 2021 Feb 22;68(3):A09200705"},{"key":"ref3","unstructured":"3. World Health Organization. (2020). Clinical management of COVID-19: interim guidance. Retrieved from https:\/\/www.who.int\/publications\/i\/ item\/clinical-management-of-covid-19."},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"4. Venkatesan P. NICE guideline on long COVID. Lancet Respir Med. 2021;9(2):129. doi: 10.1016\/S2213-2600(21)00031-X,","DOI":"10.1016\/S2213-2600(21)00031-X"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"5. Mitevska I, Poposka L. Coronavirus Disease-19 and Cardiovascular Disease. Open Access Maced J Med Sci. 2020,8(T1):39-44. https:\/\/doi.org\/10.3889\/ oamjms.2020.4804","DOI":"10.3889\/oamjms.2020.4804"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"6. Liu PP, Blet A, Smyth D, Li H. The science underlying COVID-19: implications for the cardiovascular system. Circulation 2020;142:68-78. doi: 10.1161\/CIRCULATIONAHA.120.047549","DOI":"10.1161\/CIRCULATIONAHA.120.047549"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"7. G\u00fcnster C, Busse R, Spoden M, Rombey T, et al. 6-month mortality and readmissions of hospitalized COVID-19 patients: A nationwide cohort study of 8,679 patients in Germany. PLoS One. 2021 Aug 5;16(8):e0255427. doi: 10.1371\/journal.pone.0255427","DOI":"10.1371\/journal.pone.0255427"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"8. Huang C, Huang L, Wang Y, Li X, et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021;397(10270):220-32. doi: 10.1016\/S0140-6736(20)32656-8","DOI":"10.1016\/S0140-6736(20)32656-8"},{"key":"ref9","unstructured":"9. Natural History of Post-Coronavirus Disease 19 Convalescence at the National Institutes of Health. Clinicaltrials.gov n.d. Available from: https:\/\/ clinicaltrials.gov\/ct2\/show\/NCT04573062"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"10. Ayoubkhani D, Khunti K, Nafilyan V,Maddox T, et al. Post-covid syndrome in individuals admitted to hospital with covid-19: retrospective cohort study. BMJ. 2021;372:n693. doi: 10.1136\/bmj.n693.","DOI":"10.1136\/bmj.n693"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"11. COVID-ICU Group on behalf of the REVA Network and the COVID-ICU nvestigators. Clinical characteristics and day-90 outcomes of 4244 critically ill adults with COVID-19: a prospective cohort study. Intensive Care Med. 2021;47(1):60-73. doi: 10.1007\/s00134-020-06294-x","DOI":"10.1007\/s00134-020-06294-x"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"12. Johansson M, St\u00e5hlberg M, Runold M, Nygren-Bonnier M, et al. Long-Haul Post-COVID-19 Symptoms Presenting as a Variant of Postural Orthostatic Tachycardia Syndrome: The Swedish Experience. JACC Case Rep. 2021;3(4):573-80. doi: 10.1016\/j.jaccas.2021.01.009","DOI":"10.1016\/j.jaccas.2021.01.009"},{"key":"ref13","unstructured":"13. St\u00e5hlberg M, Reistam U, Fedorowski A, Villacorta H, et al. Post-Covid-19 Tachycardia Syndrome: A distinct phenotype of Post-acute Covid-19 Syndrome. Am J Med. 2021: S0002-9343(21)00472-1. doi: 10.1016\/j. amjmed. 2021.07.004"},{"key":"ref14","unstructured":"14. Arutyunov GP, Tarlovskaya EI, Arutyunov AG, Belenkov YN, et al. [ACTIV SARS-CoV-2 registry (Analysis of Chronic Non-infectious Diseases Dynamics After COVID-19 Infection in Adult Patients). Assessment of impact of combined original comorbid diseases in patients with COVID-19 on the prognosis]. Ter Arkh. 2022 Jan 15;94(1):32-47. Russian. doi: 10.26442 \/00403660.2022.01.201320"},{"key":"ref15","unstructured":"15. Arutyunov GP, Tarlovskaya EI, Arutyunov AG, Belenkov YN, et al. International register \u201cDynamics analysis of comorbidities in SARS-CoV-2 survivors\u201d (AKTIV) and the register \u201cAnalysis of hospitalizations of comorbid patients infected during the second wave of SARS-CoV-2 outbreak\u201d (AKTIV 2). Russian Journal of Cardiology. 2021;26(3):4358. https:\/\/doi. org\/10.15829\/1560-4071-2021-4358"}],"container-title":["Journal of Medicine and Life"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/medandlife.org\/wp-content\/uploads\/19.-jml-2022-0168.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,8]],"date-time":"2023-05-08T02:33:13Z","timestamp":1683513193000},"score":1,"resource":{"primary":{"URL":"https:\/\/medandlife.org\/wp-content\/uploads\/19.-jml-2022-0168.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":15,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["JMedLife-16-447"],"URL":"https:\/\/doi.org\/10.25122\/jml-2022-0168","relation":{},"ISSN":["1844-122X","1844-3117"],"issn-type":[{"value":"1844-122X","type":"print"},{"value":"1844-3117","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3]]}}}